Inhibition of METTL3 can alleviate myocardial fibrosis and inflammation, and prevent cardiomyocyte death under reperfusion injury conditions by disrupting DNA-PKcs/Fis1-dependent mitochondrial fission. The gene discussed is PRKDC; the disease is Myocardial fibrosis.